Extracorporeal Membrane Oxygenation Market Research On Present State & Future Growth Prospects To 2025

Extracorporeal Membrane Oxygenation market is poised to gain massive momentum over the projected timeline of 2019 to 2025. This can be credited to growing adoption of this treatment procedure primarily driven by the rising prevalence of respiratory disorders across the globe. Based on the estimates of WHO, nearly 200 million people are affected by chronic obstructive pulmonary disease (COPD) globally.

Escalating awareness regarding respiratory and cardiovascular disorder treatments among population coupled with surging demand for advanced clinical procedures could stimulate the demand for ECMO procedures over time. While a report published by Global Market Insights, Inc., claims that the extracorporeal membrane oxygenation market may reach USD 370 million by the year 2025.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2720

Respiratory disease application segment held a significant market share with a valuation of USD 175 million in 2018 and is projected to grow over time owing to increasing cases of respiratory failure, pulmonary diseases and lung cancer. According to the WHO, more than 1,80,000 deaths are recorded every year due to asthma. The increasing rate of respiratory disorders along with the growing awareness regarding ECMO procedure is anticipated to drive the segmental growth over the upcoming years.

Adult patient population segment is estimated to register a CAGR of 4.6% over the given timeline on account of growing incidences of acute respiratory condition among adults especially in the developing economies. As per WHO report, mortality rate among people aged above 60 years is 10 times higher than in people aged between 15 to 59. Considering these factors, demand for ECMO systems in this segment is anticipated to rise exponentially.

In regards to regional outlook, Canada is considered to be a promising avenue for ECMO industry players. Earlier in 2018, Canada controlled almost 15% of the North America extracorporeal membrane oxygenation market share. Increasing presence of advanced healthcare infrastructure, availability of skilled healthcare professionals and growing cases of cardiovascular disorders may bolster product acceptance across Canada.

Currently, companies like Getinge, Medtronic, Hennepin healthcare, Terumo, LivaNova, Alung Technologies, and Abbott are dictating the extracorporeal membrane oxygenation market. With the coronavirus affecting patients breathing capability, these companies are offering ECMO solution to provided needed relief and support recovery. Highlighting an instance, in June 2020, Medtronic momentarily tweaked its product indications to help health providers use ECMO technology to treat patients with severe COVID-19. Rising cases of coronavirus worldwide will majorly boost the demand for ECMO solutions.

Request for customization @ https://www.gminsights.com/roc/2720

Partial Chapter of the Table of Content

Chapter 5. Extracorporeal Membrane Oxygenation Market, By Application

5.1. Key segment trends

5.2. Cardiac diseases

5.2.1. Market size, by region, 2014 - 2025

5.3. Respiratory diseases

5.3.1. Market size, by region, 2014 - 2025

5.4. Extracorporeal cardiopulmonary resuscitation (ECPR)

5.4.1. Market size, by region, 2014 - 2025

Chapter 6. Extracorporeal Membrane Oxygenation Market, By Patient Population

6.1. Key segment trends

6.2. Infant

6.2.1. Market size, by region, 2014 - 2025

6.3. Pediatric

6.3.1. Market size, by region, 2014 – 2025

6.4. Adult

6.4.1. Market size, by region, 2014 - 2025

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/extracorporeal-membrane-oxygenation-market